- Home
- ACTG vs MGTX Comparison
ACTG vs MGTX Comparison
Compare ACTG & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTG
- MGTX
- Stock Information
- Founded
- ACTG 1993
- MGTX 2015
- Country
- ACTG United States
- MGTX United States
- Employees
- ACTG N/A
- MGTX 372
- Industry
- ACTG Multi-Sector Companies
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ACTG Miscellaneous
- MGTX Health Care
- Exchange
- ACTG Nasdaq
- MGTX Nasdaq
- Market Cap
- ACTG 363.5M
- MGTX 520.8M
- IPO Year
- ACTG 1996
- MGTX N/A
- Fundamental
- Price
- ACTG $3.79
- MGTX $8.25
- Analyst Decision
- ACTG
- MGTX Strong Buy
- Analyst Count
- ACTG 0
- MGTX 2
- Target Price
- ACTG N/A
- MGTX $24.00
- AVG Volume (30 Days)
- ACTG 167.2K
- MGTX 480.9K
- Earning Date
- ACTG 08-07-2025
- MGTX 08-11-2025
- Dividend Yield
- ACTG N/A
- MGTX N/A
- EPS Growth
- ACTG N/A
- MGTX N/A
- EPS
- ACTG N/A
- MGTX N/A
- Revenue
- ACTG $222,414,000.00
- MGTX $34,508,000.00
- Revenue This Year
- ACTG $141.36
- MGTX $365.04
- Revenue Next Year
- ACTG N/A
- MGTX $73.18
- P/E Ratio
- ACTG N/A
- MGTX N/A
- Revenue Growth
- ACTG 65.22
- MGTX 203.23
- 52 Week Low
- ACTG $2.70
- MGTX $3.85
- 52 Week High
- ACTG $5.70
- MGTX $8.75
- Technical
- Relative Strength Index (RSI)
- ACTG 56.38
- MGTX 77.78
- Support Level
- ACTG $3.68
- MGTX $6.31
- Resistance Level
- ACTG $3.82
- MGTX $6.80
- Average True Range (ATR)
- ACTG 0.11
- MGTX 0.39
- MACD
- ACTG 0.01
- MGTX 0.16
- Stochastic Oscillator
- ACTG 86.67
- MGTX 97.11
About ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations and Manufacturing Operations. It derives revenue from Intellectual Property Operations segment. Geographically, it operates in Americas, Europe, Middle East and Africa, China, India, and Asia-Pacific, excluding China and India.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.